Jarvis
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
No Result
View All Result
Home Stock Market News Updates

Friday, 8th October 2021

by Sumit Chanda
October 8, 2021
in Stock Market News Updates
Reading Time: 4 mins read
A A
0
Share on FacebookShare on Twitter

Rating agency, Fitch, cut its FY22 India growth forecast from 10% to 8.7%. They cited the long-term impact of COVID 2.0 as a key reason which would back-end growth. However, Fitch has upgraded the growth forecast for FY23 from 8.5% to 10%. Unlike Moody’s, which raised India’s outlook from negative to stable, Fitch has decided to hold on to India’s negative outlook. It has cited high fiscal deficit, rising debt levels and slower than expected GDP growth as key risks. Another major risk could be high inflation levels.

Piramal Enterprises announced the demerger of its pharma business from the financial services business. The idea is to simplify the corporate structure and derive better value by creating two specialized listed entities. Details of the composite scheme of arrangement  are awaited. The pharma business will get consolidated under Piramal Pharma (PPL). Shareholders of PEL will get 4 shares of PPL for 1 share of PEL, while they will retain their holding in PEL. PPL is likely to emerge among the largest Indian pharma plays. 

Zee had a temporary reprieve as the NCLAT gave Zee more time to file a reply to the demand for an EGM put forth by Invesco Fund and OFI Global China Fund. Invesco had called for an EGM to seek the removal of Punit Goenka from the post of MD and CEO and nominate 6 of its own directors. The NCLAT order has pointed that NCLT had committed an error by not giving enough time to Zee to file a reply under the principle of natural justice. NCLT had given just 36 hours to Zee to file the reply, while the norm is 90 days.

SEBI is unlikely to exempt the acquirer of BPCL from making mandatory open offers for Petronet LNG and IGL. BPCL holds 12.5% in Petronet and 22.5% in IGL. As promoter of Petronet and IGL, BPCL holds board positions. As per the current legal position, the acquirer will have to make open offers to the shareholders of Petronet and IGL to buy 26% shares. SEBI is unlikely to accede to the request in the larger interests minority shareholders. BPCL has unwilling to reduce its stake in Petronet and IGL as it would deplete value. 

Tata Motors rallied 10% and scaled a fresh 3-year high on strong business outlook. Morgan Stanley has already upgraded the price target of Tata Motors to Rs.448 from Rs.298 earlier. In fact, the Morgan report expects the future value creation for Tata Motors to come from the India business rather than from Jaguar Land Rover. Tata Motors is likely to enjoy the highest operating and financial leverage gains in the PV and CV segments. Even the Tata Motors DVR surged 7% and has been one of the best performing stocks.

In an expected move, the Bombay High Court dismissed SREI Group’s plea against RBI action on SREI Infrastructure Finance and SREI Equipment Finance. Earlier, SREI group had sought a stay on the RBI insolvency proceedings against the two entities. After the court order, Hemant Kanoria underlined that the SREI group had done its best to abide by the conditions imposed by RBI and the banks. Last week, SREI had asked for a 1-year standstill for collection of dues. Subsequently, banks had asked RBI to intervene.

Ahead of its Rs.16,600 crore IPO, Paytm is talking to sovereign wealth funds and large investors to participate as anchor investors in Paytm. Some of the major sovereign funds that are evaluating the offer are Abu Dhabi Investment Authority and GIC of Singapore. Paytm may seek a valuation of $20-22 billion in the IPO. Paytm has filed the DRHP with SEBI and is awaiting approval. It has also been talking to marquee investors like Nomura of Japan and Blackrock. Paytm is backed by Berkshire Hathaway and the Ant Group. 

Godrej Consumer Products Limited rolled out a range of baby care products in India and it will be riding on the demand for branded oils, soaps and shampoos for children. These products will be launched under the “Goodnessme” brand and will be targeted at 0-2 year olds. The range of baby products is positioned as organic, vegan and cruelty-free. Johnson & Johnson has been a dominant player in this space for a very long time. This launch will also be a digital-first launch. Organic baby products is clearly a unique niche.

Sumit Chanda

Sumit Chanda

Sumit has 18 years of experience in BFSI industry, into devising strategy for various functions, Investments and Managing Asset Portfolios. Specializes in Strategy & implementation in sales & operations, Team management, IT implementation, Affiliations.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Jarvis Invest

India's AI-powered, SEBI-registered investment advisory — research, portfolios and global market intelligence for every investor.

Company

  • About Us
  • FAQs
  • Contact Us
  • Become a Partner

Products

  • Jarvis Portfolio
  • Jarvis Protect
  • Jarvis OneStock
  • Jarvis Prime
  • Sentiment Tracker (F&O)
  • US Multi-Asset Portfolio

Explore Topics

  • Equity Markets
  • Investing Basics
  • AI for investing
  • Trending Stock Market News: Quick Reads
  • Financial Planning
  • Portfolio Management
  • Stock Market News Updates
  • Global Stock Market

Get in touch

Customer support customersupport@jarvisinvest.com

Jarvis Invest — SEBI Registered Investment Adviser (Reg. No. INA000013235) & SEBI Registered Research Analyst (Reg. No. INH000018762). Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

© 2026 Jarvis Invest. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Categories
Equity MarketsGet latest insights on the Indian equity market including stock trends, market analysis, sector…Investing BasicsLearn stock market basics including investing fundamentals, equity concepts, and beginner-friendly guides to start…AI for investingStay ahead with AI-powered stock insights, trend analysis, and intelligent investing strategies for ai…Trending Stock Market News: Quick ReadsDiscover the latest trends in the stock market with insightful blogs from Jarvis Invest…Portfolio ManagementExpert insights on portfolio management, asset allocation, risk management, and strategies to optimise best…Stock Market News UpdatesGet daily stock market news updates, key market movements, and insights that matter to…Global Stock MarketGet latest global stock market news, trends, and AI-driven stock insights on US, Europe…Stock AdvisoryLearn how AI-powered stock advisory and expert market research can help you build wealth.
I Am A
BeginnerBeginner-friendly stock market guides covering investing basics, common mistakes, and simple strategies to build…IntermediateIntermediate-level stock market insights covering investment strategies, portfolio analysis, and market concepts for informed…
Products
Jarvis PortfolioModel portfolio matched to your risk profile for long-term wealth creation.Jarvis ProtectContinuous portfolio monitoring for your existing portfolio with timely sell alerts to help manage downside risk.Jarvis OneStockHigh-conviction stock recommendations designed for short-term investing.Jarvis Prime - For HNIs & UHNIsPremium portfolio management services for investors with ₹25 lakh+ investment corpus.Jarvis Sentiment Tracker - AI Tool for F&OReal-time market sentiment analysis and trading signals for options traders.Jarvis US Multi-Asset PortfolioDiversified US portfolio investing across stocks and ETFs with automated portfolio management.Jarvis AtlasInvestment opportunities across Indian equities, global markets, and commodities in 10+ global markets.
No Result
View All Result
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner

© 2023 Jarvis Invest

Go to mobile version